Ruslan Medzhitov (born March 12, 1966) is a professor of immunobiology and dermatology at the Yale School of Medicine, and an investigator at the Howard Hughes Medical Institute. His research focuses on the analysis of the innate immune system, inflammatory response, innate control of the adaptive immunity, and host-pathogen interactions. In 2010, he was elected to the National Academy of Sciences, and in 2017 he was named Sterling Professor.
Before coming to Yale, he was a fellow in the laboratory of Russell Doolittle at the University of California, San Diego. He did his post-doctoral training with Janeway at Yale University School of Medicine from 1994 to 1999.
In 1997, Medzhitov and Janeway proved that humans have a Toll-like receptor (later named TLR4 ), which activates genes necessary for the immune response. In 2000, Medzhitov was selected as a Searle Scholar. On April 27, 2010, he was elected to the US National Academy of Sciences and became one of the youngest academicians. In 2011, the Russian edition of Forbes magazine published a list of 50 Russians who “conquered the world”. It includes scientists, businessmen, cultural and sports figures who have integrated into the world community and have achieved success outside of Russia. Medzhitov was included in this Forbes list of 10 famous scientists of Russian origin.
On May 15, 2012, Medzhitov was awarded a diploma and a medal of the Honorary Professor at Moscow State University. Currently, he serves as a Sterling professor at the Yale University School of Medicine.
In recognition of his prolific contributions to the field of immunological research, he was elected to the National Academy of Sciences and in 2011 he was a co-recipient of the Shaw Prize in Life Science and Medicine. In 2013, Medzhitov received the Vilcek Prize in Biomedical Science.
|
|